Search

Publications

The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review
Salek, S. ; Ionova, T. ; Oliva, E. N. ; Andreas, M. ; Skoetz, N. ; Kreuzberger, N. ; Laane, E.

Read more

I would like to renew my EHA membership

Renew your EHA membership to ensure that you will be able continue enjoying your membership benefits all year round.

Read more

New GFI1B variants in bleeding and platelet disorders

Platelets restrict blood loss upon vessel damage by formation of a clot (thrombus). Recently, we reported a family with a bleeding and platelet disorder (BPD), which was caused by a defect in the gene GFI1B1.

Read more

YoungEHA Committee

Current committee members
Mandy Lauw, The Netherlands (Chair)
Anna Kabanova, Italy (Vice Chair)
Elizabeth Macintyre, France (EHA Past President)
Regular members
Anna Avagyan, Armenia 
Nuno Borges, United Kingdom 
Katherine Bridge, United Kingdom 
Lorenzo Brunetti, Italy 
Eleni Gavriilaki, Greece 
William Grey, United Kingdom 
Ruxandra Irimia, Romania
Rafal Machowicz, Poland
Anna Maiques Diaz, Spain
Ana Filipa…

Read more

SWG Educational Activities

EICMLThe 2023 EICML meeting took place in Naples in May 2023. Fifty-five physicians and scientists met at the Palazzo Alabardieri in central Naples to spend two days discussing emerging data and developing collaborations.

Read more

A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukemia

Patients with chronic lymphocytic leukemia (CLL) that has recurred or isn’t responding to standard treatment need new therapies. A new combination of two targeted therapies is showing potential to eliminate CLL in these circumstances.

Read more

Partnerships

EHA's approach to policy and regulatory affairs involves collaboration across medical professions and disciplines.

Read more